Use of Probiotics to Prevent Celiac Disease and IBD in Pediatrics

Area of Science:

• Microbiome research
• Chronic inflammatory diseases (CIDs)
• Gut health and immunology

Background:

• Chronic inflammatory diseases (CIDs) are increasing globally, posing significant health challenges, particularly for children.
• Current research indicates a link between intestinal dysbiosis (microbial imbalance) and active CIDs, but mechanistic insights are lacking.
• Effective therapeutic strategies for CIDs are limited, highlighting the need for a deeper understanding of disease pathophysiology.

Purpose of the Study:

• To explore the contribution of the gut microbiome to the development of celiac disease and inflammatory bowel disease.
• To investigate the potential of probiotics as a preventive therapy for CIDs.
• To emphasize the need for prospective studies and systems-level models integrating multi-omics data for a comprehensive understanding of host-microbiome interactions in CIDs.

Main Methods:

• Review of current knowledge on the microbiome's role in CIDs.
• Analysis of cross-sectional studies linking intestinal dysbiosis to active diseases.
• Discussion of systems-level modeling approaches integrating microbiome, metagenomics, metatranscriptomics, and metabolomics data.

Main Results:

• Cross-sectional studies suggest an association between intestinal dysbiosis and active CIDs.
• Mechanistic links between microflora alterations and disease pathogenesis require further investigation through prospective studies.
• Multi-omics data integration with clinical and environmental factors is crucial for understanding complex host-microbiome interactions.

Conclusions:

• Intestinal dysbiosis is implicated in CIDs, but its causative role needs prospective validation.
• Probiotics show potential as a preventive therapy for CIDs.
• A systems-level approach is essential to unravel the complex interplay between the host microbiome and disease development.